The idea that the cost of engaging patients in the development process is too much – too much time, too much money, too much work – is the worst sort…
Patient Advocacy Strategies To Set You Up for 2026 and Beyond This time of year, many in pharma and biotech are looking at budgets with an eye toward action: what…
Patient councils are having a moment. Once a new innovation in patient engagement, they are now increasingly the norm among healthcare companies—and for good reason. By establishing a council, often…
As longtime advocates for caregivers, we were pleased to see the recent post from Eye for Pharma, “Pharma’s new ally: the caregiver,” which outlined the many ways that caregivers could…
We read with great interest the Opinion piece in Stat News in which more than 200 corporate leaders—mostly from small and mid-sized companies, as well as some investors—signed on to what…
Topline findings from a survey of more than 600 caregivers now available for download.
Learn More